The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Derek Weycker

Policy Analysis Inc. (PAI)

Four Davis Court

Brookline

MA, 02445

USA

[email]@pai2.com

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Policy Analysis Inc. (PAI), Four Davis Court, Brookline, MA, 02445, USA. 2005 - 2012

References

  1. Incidence of reduced chemotherapy relative dose intensity among women with early stage breast cancer in US clinical practice. Weycker, D., Barron, R., Edelsberg, J., Kartashov, A., Lyman, G.H. Breast Cancer Res. Treat. (2012) [Pubmed]
  2. Risk of hospitalization for neutropenic complications of chemotherapy in patients with primary solid tumors receiving pegfilgrastim or filgrastim prophylaxis: a retrospective cohort study. Weycker, D., Malin, J., Kim, J., Barron, R., Edelsberg, J., Kartashov, A., Oster, G. Clin. Ther (2009) [Pubmed]
  3. Excess risk of diabetes in persons with hypertension. Weycker, D., Nichols, G.A., O'Keeffe-Rosetti, M., Edelsberg, J., Vincze, G., Khan, Z.M., Oster, G. J. Diabetes Complicat. (2009) [Pubmed]
  4. Cost of routine immunization of young children against rotavirus infection with Rotarix versus RotaTeq. Weycker, D., Sofrygin, O., Kemner, J.E., Pelton, S.I., Oster, G. Vaccine (2009) [Pubmed]
  5. Effectiveness of add-on therapy with amlodipine in hypertensive patients receiving valsartan. Weycker, D., Keskinaslan, A., Levy, D.G., Edelsberg, J., Kartashov, A., Oster, G. Blood. Press. Suppl (2008) [Pubmed]
  6. Effectiveness of add-on therapy with amlodipine in hypertensive patients receiving valsartan. Weycker, D., Keskinaslan, A., Levy, D.G., Edelsberg, J., Kartashov, A., Oster, G. Blood Press. (2008) [Pubmed]
  7. Blood pressure control in patients initiating antihypertensive therapy. Weycker, D., Edelsberg, J., Vincze, G., Levy, D.G., Kartashov, A., Oster, G. Ann. Pharmacother (2008) [Pubmed]
  8. Cost of neutropenic complications of chemotherapy. Weycker, D., Malin, J., Edelsberg, J., Glass, A., Gokhale, M., Oster, G. Ann. Oncol. (2008) [Pubmed]
  9. Effectiveness of add-on therapy with amlodipine in hypertensive patients receiving valsartan. Weycker, D., Keskinaslan, A., Levy, D.G., Edelsberg, J., Kartashov, A., Oster, G. Blood Press. (2008) [Pubmed]
  10. Risk of diabetes in a real-world setting among patients initiating antihypertensive therapy with valsartan or amlodipine. Weycker, D., Edelsberg, J., Vincze, G., Kjeldsen, S.E., Jamerson, K., Khan, Z.M., Oster, G. J. Hum. Hypertens (2007) [Pubmed]
  11. Cost-effectiveness of memantine in moderate-to-severe Alzheimer's disease patients receiving donepezil. Weycker, D., Taneja, C., Edelsberg, J., Erder, M.H., Schmitt, F.A., Setyawan, J., Oster, G. Curr. Med. Res. Opin (2007) [Pubmed]
  12. Compliance with osteoporosis drug therapy and risk of fracture. Weycker, D., Macarios, D., Edelsberg, J., Oster, G. Osteoporos. Int (2007) [Pubmed]
  13. Risk-factor clustering and cardiovascular disease risk in hypertensive patients. Weycker, D., Nichols, G.A., O'Keeffe-Rosetti, M., Edelsberg, J., Khan, Z.M., Kaura, S., Oster, G. Am. J. Hypertens. (2007) [Pubmed]
  14. Are shorter courses of filgrastim prophylaxis associated with increased risk of hospitalization?. Weycker, D., Hackett, J., Edelsberg, J.S., Oster, G., Glass, A.G. Ann. Pharmacother (2006) [Pubmed]
  15. Compliance with drug therapy for postmenopausal osteoporosis. Weycker, D., Macarios, D., Edelsberg, J., Oster, G. Osteoporos. Int (2006) [Pubmed]
  16. Retrospective study of the costs of care during the first year of therapy with etanercept or infliximab among patients aged > or =65 years with rheumatoid arthritis. Weycker, D., Yu, E.B., Woolley, J.M., Oster, G. Clin. Ther (2005) [Pubmed]
 
WikiGenes - Universities